Biotech

All Articles

Turnstone gives up 60%, agitates C-suite to extend money

.Turnstone Biologics is lowering its headcount through 60% and also agitating its C-suite in order t...

Gilead gives up on $15M MASH wager after reviewing preclinical data

.In a year that has actually observed an approval as well as a plethora of readouts for metabolic dy...

Texas biotech centers cancer cells pact, pins really hopes on obesity

.Alaunos Therapeutics is actually axing a deal with Precigen, surrendering licensing civil rights to...

Capricor reveals a lot more data for DMD therapy after triggering BLA

.Capricor Therapies is actually taking a triumph tour for their stage 2 Duchenne muscular dystrophy ...

FDA areas Kezar lupus trial in hold complying with 4 client deaths

.The FDA has actually placed Kezar Lifestyle Sciences' lupus trial on grip after the biotech hailed ...

Phase 3 Scholar Stone test reaches SMA target, delivering stockpile 200%

.A stage 3 trial of Historian Stone's back muscle atrophy (SMA) applicant has actually reached its m...

CAMP 4 is newest to eye IPO, while Upstream define $182M planning

.RNA biotech CAMP4 Therapies has defined prepare for a $67 million IPO, along with inflammation-focu...

Galecto purchases leukemia drug, drops bone tissue cancer cells property in pivot

.A year after the failure of an idiopathic lung fibrosis candidate delivered Galecto on a seek redem...

Judo tosses down $100M to knock senseless kidney illness

.Taking the floor covering is Judo Bio, an up-and-coming biotech equipped with $100 million to build...

AstraZeneca spends CSPC $100M for preclinical heart problem medication

.AstraZeneca has actually settled CSPC Drug Team $100 million for a preclinical heart disease drug. ...